| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| International sales | | | | | 835.4 | | | |
| Total revenues [+] | 16.9 | 13.4 | 12.3 | 3.9 | 4.7 | | 2.1 | 1.7 |
| Licensing | 0.0 | 0.2 | | 0.0 | 2.0 | | | |
| Net interest income | -1.4 | -0.5 | -0.3 | | | | | |
| Revenue growth | 25.5% | 8.9% | 218.9% | -18.3% | | | 27.3% | |
| Cost of goods sold [+] | 7.7 | 7.4 | 7.1 | 1.4 | 0.9 | | 0.6 | 0.5 |
| Cost of product sales | 1.8 | 1.5 | 1.2 | | | | | |
| Cost of licensing | 5.9 | 5.8 | 5.9 | 0.5 | | | | |
| Gross profit | 9.2 | 6.1 | 5.2 | 2.5 | 3.8 | | 1.6 | 1.1 |
| Gross margin | 54.4% | 45.0% | 42.2% | 63.4% | 80.0% | | 73.7% | 68.8% |
| Selling, general and administrative | 10.1 | 9.5 | 8.9 | 3.0 | 2.5 | | 2.0 | 2.1 |
| Research and development | | | 0.0 | 0.0 | -0.1 | | 0.1 | 0.1 |
| Other operating expenses | 1.6 | 1.5 | 0.8 | 1.0 | 0.4 | | -0.4 | -0.6 |
| EBITDA [+] | -1.1 | -3.6 | -3.7 | -1.4 | 1.1 | | | |
| EBITDA growth | -70.9% | -1.3% | 160.7% | -223.8% | | | -105.5% | |
| EBITDA margin | -6.2% | -26.9% | -29.7% | -36.3% | 24.0% | | 0.6% | -12.8% |
| Depreciation | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | | | |
| EBITA | -1.3 | -3.9 | -3.9 | -1.5 | 1.0 | | 0.0 | -0.2 |
| EBITA margin | -7.5% | -28.8% | -31.7% | -39.2% | 21.8% | | 0.6% | -12.8% |
| Amortization of intangibles | 1.3 | 1.0 | 0.5 | 0.0 | | | 0.1 | 0.1 |
| EBIT [+] | -2.6 | -4.9 | -4.4 | -1.5 | 1.0 | | -0.1 | -0.4 |
| EBIT growth | -47.1% | 10.6% | 186.4% | -250.2% | | | -68.2% | |
| EBIT margin | -15.4% | -36.5% | -35.9% | -40.0% | 21.8% | | -5.4% | -21.7% |
| Non-recurring items [+] | | -0.2 | | -0.8 | 0.0 | | 0.0 | |
| Restructuring charges | | | | -0.7 | | | | |
| Loss (gain) on sale of assets | | -0.2 | | -0.3 | 0.0 | | | |
| Loss (gain) on disposal of assets | | | | -0.3 | | | | |
| Interest income | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | | | |
| Interest income | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | | | |
| Other income (expense), net [+] | | | | | | | 0.1 | 0.4 |
| Gain (loss) on derivative instruments | 0.3 | -0.4 | 0.2 | 0.2 | 0.0 | | | |
| Change in value of contingent liability | | | 0.1 | | | | | |
| Other | 0.3 | -0.4 | 0.2 | -0.2 | | | | |
| Pre-tax income | -2.5 | -4.7 | -4.4 | -0.7 | 1.1 | | 0.0 | 0.0 |
| Income taxes | 3.1 | 1.8 | -1.1 | -0.2 | 0.5 | | 0.0 | 0.0 |
| Tax rate | | | 24.2% | 24.0% | 50.3% | | | |
| Net income | -5.6 | -6.6 | -3.3 | -0.5 | 0.5 | | 0.0 | 0.0 |
| Net margin | -33.2% | -48.9% | -27.1% | -13.5% | 11.1% | | 0.0% | 0.0% |
| |
| Basic EPS [+] | ($0.04) | ($0.10) | ($0.11) | ($0.03) | $0.04 | | | |
| Growth | -63.5% | -14.6% | 322.8% | -160.0% | | | | |
| Diluted EPS [+] | ($0.04) | ($0.10) | ($0.11) | ($0.03) | $0.04 | | $0.00 | $0.00 |
| Growth | -63.5% | -14.6% | 322.8% | -160.0% | | | | |
| |
| Shares outstanding (basic) [+] | 71.9 | 49.2 | 39.2 | 25.7 | 23.8 | | | |
| Growth | 46.3% | 25.5% | 52.4% | 8.2% | | | | |
| Shares outstanding (diluted) [+] | 71.9 | 49.2 | 39.2 | 25.7 | 23.8 | | 23.8 | 23.8 |
| Growth | 46.3% | 25.5% | 52.4% | 8.2% | | | -0.1% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |